177 related articles for article (PubMed ID: 32216700)
1. Peptide-Based Monoclonal Antibody Production Against SAG1 (P30) Protein of
Naghi Vishteh M; Javadi Mamaghani A; Rashidi S; Seyyed Tabaei SJ; Jeddi-Tehrani M
Monoclon Antib Immunodiagn Immunother; 2020 Apr; 39(2):51-56. PubMed ID: 32216700
[No Abstract] [Full Text] [Related]
2. Reactivity of synthetic SAG1 (p30) peptide sequences with RH, S273 and Beverley strain-induced anti-Toxoplasma gondii antibodies.
Kato M; Claveria FG; Maki Y; Sanda K; Tanaka T; Omata Y; Nagasawa H; Suzuki N
Pathobiology; 2007; 74(1):50-6. PubMed ID: 17496433
[TBL] [Abstract][Full Text] [Related]
3. Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice.
Han Y; Zhou A; Lu G; Zhao G; Wang L; Guo J; Song P; Zhou J; Zhou H; Cong H; He S
BMC Infect Dis; 2017 Jan; 17(1):59. PubMed ID: 28077075
[TBL] [Abstract][Full Text] [Related]
4. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
[TBL] [Abstract][Full Text] [Related]
5. Biological role of surface Toxoplasma gondii antigen in development of vaccine.
Liu KY; Zhang DB; Wei QK; Li J; Li GP; Yu JZ
World J Gastroenterol; 2006 Apr; 12(15):2363-8. PubMed ID: 16688826
[TBL] [Abstract][Full Text] [Related]
6. Expression of in vivo biotinylated recombinant antigens SAG1 and SAG2A from Toxoplasma gondii for improved seroepidemiological bead-based multiplex assays.
Klein S; Stern D; Seeber F
BMC Biotechnol; 2020 Oct; 20(1):53. PubMed ID: 33023547
[TBL] [Abstract][Full Text] [Related]
7. Reverse enzyme-linked immunosorbent assay using monoclonal antibodies against SAG1-related sequence, SAG2A, and p97 antigens from Toxoplasma gondii to detect specific immunoglobulin G (IgG), IgM, and IgA antibodies in human sera.
Carvalho FR; Silva DA; Cunha-Júnior JP; Souza MA; Oliveira TC; Béla SR; Faria GG; Lopes CS; Mineo JR
Clin Vaccine Immunol; 2008 Aug; 15(8):1265-71. PubMed ID: 18562566
[TBL] [Abstract][Full Text] [Related]
8. Production of the main surface antigen of Toxoplasma gondii in tobacco leaves and analysis of its antigenicity and immunogenicity.
Clemente M; Curilovic R; Sassone A; Zelada A; Angel SO; Mentaberry AN
Mol Biotechnol; 2005 May; 30(1):41-50. PubMed ID: 15805575
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response.
Graille M; Stura EA; Bossus M; Muller BH; Letourneur O; Battail-Poirot N; Sibaï G; Gauthier M; Rolland D; Le Du MH; Ducancel F
J Mol Biol; 2005 Nov; 354(2):447-58. PubMed ID: 16242717
[TBL] [Abstract][Full Text] [Related]
10. A4D12 monoclonal antibody recognizes a new linear epitope from SAG2A Toxoplasma gondii tachyzoites, identified by phage display bioselection.
Cunha-Júnior JP; Silva DA; Silva NM; Souza MA; Souza GR; Prudencio CR; Pirovani CP; Cezar M Cascardo J; Barbosa BF; Goulart LR; Mineo JR
Immunobiology; 2010; 215(1):26-37. PubMed ID: 19261354
[TBL] [Abstract][Full Text] [Related]
11. Toxoplasma gondii-Derived Synthetic Peptides Containing B- and T-Cell Epitopes from GRA2 Protein Are Able to Enhance Mice Survival in a Model of Experimental Toxoplasmosis.
Bastos LM; Macêdo AG; Silva MV; Santiago FM; Ramos EL; Santos FA; Pirovani CP; Goulart LR; Mineo TW; Mineo JR
Front Cell Infect Microbiol; 2016; 6():59. PubMed ID: 27313992
[TBL] [Abstract][Full Text] [Related]
12. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
[TBL] [Abstract][Full Text] [Related]
13. Design and characterization of a recombinant colorimetric SAG1-alkaline phosphatase conjugate to detect specific antibody responses against Toxoplasma gondii.
Chahed Bel-Ochi N; Bouratbine A; Mousli M
J Immunol Methods; 2013 Aug; 394(1-2):107-14. PubMed ID: 23727049
[TBL] [Abstract][Full Text] [Related]
14. The Development of
Ferra BT; Chyb M; Sołowińska K; Holec-Gąsior L; Skwarecka M; Baranowicz K; Gatkowska J
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673969
[TBL] [Abstract][Full Text] [Related]
15. Immunogenic characterization of the chimeric surface antigen 1 and 2 (SAG1/2) of Toxoplasma gondii expressed in the yeast Pichia pastoris.
Lau YL; Thiruvengadam G; Lee WW; Fong MY
Parasitol Res; 2011 Sep; 109(3):871-8. PubMed ID: 21455621
[TBL] [Abstract][Full Text] [Related]
16. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model.
Fang R; Feng H; Nie H; Wang L; Tu P; Song Q; Zhou Y; Zhao J
Vaccine; 2010 Feb; 28(7):1803-7. PubMed ID: 20018269
[TBL] [Abstract][Full Text] [Related]
17. Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii.
Petersen E; Nielsen HV; Christiansen L; Spenter J
Vaccine; 1998 Aug; 16(13):1283-9. PubMed ID: 9682392
[TBL] [Abstract][Full Text] [Related]
18. Serodiagnosis of Toxoplasma gondii infection in cats by enzyme-linked immunosorbent assay using recombinant SAG1.
Kimbita EN; Xuan X; Huang X; Miyazawa T; Fukumoto S; Mishima M; Suzuki H; Sugimoto C; Nagasawa H; Fujisaki K; Suzuki N; Mikami T; Igarashi I
Vet Parasitol; 2001 Dec; 102(1-2):35-44. PubMed ID: 11705650
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB/c mice.
Maraghi S; Ghadiri AA; Tavalla M; Shojaee S; Abdizadeh R
Biologicals; 2019 Nov; 62():39-49. PubMed ID: 31610951
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection.
Mineo JR; McLeod R; Mack D; Smith J; Khan IA; Ely KH; Kasper LH
J Immunol; 1993 May; 150(9):3951-64. PubMed ID: 7682587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
